Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Attorney Joins the Vaccine & Gene Therapy Institute of Florida Board of Directors

Published: Thursday, February 28, 2013
Last Updated: Thursday, February 28, 2013
Bookmark and Share
The Vaccine & Gene Therapy Institute of Florida (VGTI Florida) announced the appointment of Robert L. Lord, Jr., J.D., B.C.S., F.A.C.H.E., to the Board of Directors.

Mr. Lord is Senior Vice President, Legal Services and Chief Legal Officer of Martin Health System, which serves the residents of Florida’s Treasure Coast. He is currently overseeing the construction and development of the new Martin Health System Campus located adjacent to VGTI Florida in the Tradition Center for Innovation in Port St. Lucie, Florida.

Many opportunities exist for collaboration between the lifesaving research of VGTI Florida researchers and the clinical trials conducted by doctors at Martin Health System. Both organizations are helping to improve the lives of people locally and around the world.

A board certified health law expert and healthcare executive, Mr. Lord is an administrator in Martin Health overseeing matters ranging from operations, corporate compliance, risk management and planning to litigation and governmental relations. He has been a resident of the Treasure Coast since 1969.

“We welcome Robert’s wide ranging health law background and his wealth of experience to the VGTI Florida Board of Directors,” said Jay Nelson, Ph.D., founder and Executive Director of the institute. “He has his finger on the pulse of the local community and will contribute greatly to the progress of VGTI Florida’s research translation into the clinical environments.”

Prior to joining Martin Health System, Mr. Lord was Shareholder in the law firm of Crary, Buchanan, Bowdish, Bovie, Lord & Roby, Chartered. His practice focused on both health and media law. Prior to specializing in media and health law, he had many years of experience as a civil trial attorney.

Mr. Lord holds a Bachelor of Science from Florida State University and he received his Juris Doctorate degree from Stetson University College of Law. He is board certified by The Florida Bar in Health Law and is a Fellow of the American College of Healthcare Executives.

His professional affiliations include The Florida Bar, American Health Lawyers Association, American College of Healthcare Executives, the bars of the Florida Supreme Court and the United States Supreme Court.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
New Material Opens Possibilities for Super-Long-Acting Pills
A pH-responsive polymer gel could create swallow able devices, including capsules for ultra-long drug delivery.
New Tool For Investigating RNA Gone Awry
A new technology – called “Sticky-flares” – developed by nanomedicine experts at Northwestern University offers the first real-time method to track and observe the dynamics of RNA distribution as it is transported inside living cells.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
TOPLESS Plants Provide Clues to Human Molecular Interactions
Scientists at Van Andel Research Institute have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!